According to several in vivo and in vitro studies [117,120,121], mutated TET2 causes myeloid proliferation and development of myeloid malignancies, which further suggests that TET2 may act as a tumour suppressor in maintaining the homeostasis of hematopoietic cells [122]. The gene discussed is TET2; the disease is myeloid neoplasm.